Patent
Anti-angiogenic compositions and methods of use
William L. Hunter,Lindsay S. Machan,A. Larry Arsenault +2 more
- 19 Jul 1994
1.2K
TL;DR: In this article, an anti-angiogenic factor and a polymeric carrier were used for embolization of blood vessels and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Medical device with beneficial agent delivery mechanism
John F. Shanley
- 30 Aug 2002
TL;DR: In this paper, an expandable tissue supporting device employing ductile hinges at selected points in the expandable device was presented. But the hinge configuration was not specified. And although many ductile hinge configurations are possible, the hinge cross sectional area must be smaller than a beam cross-sectional area such that as the device is expanded from a first diameter to a second diameter, the hinges experience plastic deformation while the beams are not plastically deformed.
68
Patent
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
Jesus E Gonzales,Andreas P. Termin,Esther Martinborough,Nicole Zimmerman +3 more
- 09 Aug 2004
TL;DR: The present paper relates to compounds such as those of formula (I-A) inhibitors of voltage-gated sodium channels and provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, such as pain this paper.
68
Patent
Co-use of endoluminal data and extraluminal imaging
David Tolkowsky,Ran Cohen,Eldad Klaiman,Zohar Barzelay +3 more
- 28 Jul 2011
TL;DR: In this article, an endoluminal data-acquisition device that acquires a set of end-luminal points of a lumen of a subject's body at respective locations inside the lumen, a second end-alumninal device, and a display configured to display images is described.
68
Patent
A stent-catheter assembly with a releasable connection for stent retention
David C. Gale,Klaus Kleine,Anthony J. Abbate,Svava Maria Atladottir,Bin Huang +4 more
- 18 Aug 2005
TL;DR: In this paper, the authors described a medical assembly with a stent, a catheter assembly having catheter body a balloon, and a releasable connection between the stent and the catheter.
68
Patent
Compositions useful as inhibitors of voltage-gated sodium channels
Pramod Joshi,Paul Krenitsky,Jesus E. Gonzalez,Jian Wang,Dean M. Wilson,Andreas Termin +5 more
- 11 Apr 2007
TL;DR: The present paper relates to compounds useful as inhibitors of voltage-gated sodium channels and provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
68
References
The pathogenesis of atherosclerosis: a perspective for the 1990s
TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
11.4K
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
TL;DR: It is shown that vascular endothelial growth factor (VEGF) probably functions as a hypoxia-inducible angiogenic factor and is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci and the clustering of capillaries alongside VEGF-producing cells.
4.9K
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
Patrick W. Serruys,P. de Jaegere,Ferdinand Kiemeneij,Carlos Macaya,Wolfgang Rutsch,Gr. Heyndrickx,H. Emanuelsson,Jean Marco,Victor Legrand,P. Materne +9 more
TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
David L. Fischman,Martin B. Leon,Donald S. Baim,Richard A. Schatz,Michael P. Savage,Ian M. Penn,Katherine D. Detre,Lisa Veltri,Donald R. Ricci,Masakiyo Nobuyoshi,Michael W. Cleman,Richard R. Heuser,David Almond,Paul S. Teirstein,R. David Fish,Antonio Colombo,Jeffrey C. Brinker,Jeffrey Moses,Alex Shaknovich,John N. Hirshfeld,Stephen Bailey,Stephen E. Ellis,Randal Rake,Sheldon Goldberg +23 more
TL;DR: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Donald R. Senger,Stephen J. Galli,Ann M. Dvorak,Carole A. Perruzzi,V. Susan Harvey,Harold F. Dvorak +5 more
TL;DR: Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability, and this activity is secreted by these tumor cells and a variety of other tumor cell lines in vitro.
4.2K
Related Papers (5)
Ni Ding,Michael N. Helmus +1 more
- 19 Jun 1998
Eric P. Berg,Ronald J. Tuch,Michael Dror,Rodney G. Wolff +3 more
- 07 Jun 1995